Edition:
United Kingdom

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,481.40GBp
1:49pm BST
Change (% chg)

-15.40 (-1.03%)
Prev Close
1,496.80
Open
1,493.80
Day's High
1,496.20
Day's Low
1,478.40
Volume
3,314,480
Avg. Vol
8,036,623
52-wk High
1,634.48
52-wk Low
1,235.20

Chart for

About

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare... (more)

Overall

Beta: 1.21
Market Cap(Mil.): £75,181.28
Shares Outstanding(Mil.): 4,918.63
Dividend: 19.00
Yield (%): --

Financials

  GSK.L Industry Sector
P/E (TTM): 38.75 30.93 32.76
EPS (TTM): 0.39 -- --
ROI: 7.58 15.07 14.61
ROE: 278.84 16.59 16.33

Nestle aims to shed skin unit to focus on food, nutrition

LONDON/ZURICH Nestle put its skin health unit up for sale on Thursday, as the maker of Nescafe and Perrier water ditches underperforming businesses and fends off criticism from an activist investor demanding an overhaul.

12:46pm BST

Nestle aims to shed skin unit to focus on food, nutrition

LONDON/ZURICH Nestle put its skin health unit up for sale on Thursday, as the maker of Nescafe and Perrier water ditches underperforming businesses and fends off criticism from an activist investor demanding an overhaul.

12:45pm BST

UPDATE 3-Nestle aims to shed skin unit to focus on food, nutrition

* Hedge fund Third Point demanding bolder corporate moves (Changes headline, adds context, comments)

12:42pm BST

PRESS DIGEST- Financial Times - Sept 19

Sept 19 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

19 Sep 2018

Coca-Cola buys Australia's kombucha maker Mojo

Coca-Cola Co said on Tuesday it bought Australia-based Organic & Raw Trading Co, known for its Mojo brand of kombucha tea, extending its push into healthier drinks.

18 Sep 2018

Coca-Cola buys Australia's kombucha maker Mojo

Coca-Cola Co said on Tuesday it bought Australia-based Organic & Raw Trading Co, known for its Mojo brand of kombucha tea, extending its push into healthier drinks.

18 Sep 2018

GSK grabs new drug development head from Boehringer

LONDON GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said on Tuesday.

18 Sep 2018

GSK grabs new drug development head from Boehringer

LONDON GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said on Tuesday.

18 Sep 2018

GSK grabs new drug development head from Boehringer

LONDON, Sept 18 GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said on Tuesday.

18 Sep 2018

GSK says U.S. FDA wants more information on pulmonary drug

LONDON GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD).

07 Sep 2018

Earnings vs. Estimates